Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Depreciation and Depletion (2018 - 2020)

enVVeno Medical has reported Depreciation and Depletion over the past 3 years, most recently at $33143.0 for Q4 2020.

  • Quarterly results put Depreciation and Depletion at $33143.0 for Q4 2020, up 72.72% from a year ago — trailing twelve months through Dec 2020 was $100000.0 (up 117.31% YoY), and the annual figure for FY2025 was $100000.0, down 50.0%.
  • Depreciation and Depletion for Q4 2020 was $33143.0 at enVVeno Medical, up from $21896.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for NVNO hit a ceiling of $33143.0 in Q4 2020 and a floor of $2380.0 in Q1 2018.
  • Median Depreciation and Depletion over the past 3 years was $11881.5 (2019), compared with a mean of $13010.8.
  • Peak annual rise in Depreciation and Depletion hit 584.83% in 2019, while the deepest fall reached 28.78% in 2019.
  • enVVeno Medical's Depreciation and Depletion stood at $2802.0 in 2018, then skyrocketed by 584.83% to $19189.0 in 2019, then surged by 72.72% to $33143.0 in 2020.
  • The last three reported values for Depreciation and Depletion were $33143.0 (Q4 2020), $21896.0 (Q3 2020), and $25285.0 (Q2 2020) per Business Quant data.